Journal Article

Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors

Collignon, Evelyne, Deplus, Rachel, Putmans, Pascale, Yuan, Bi-Feng, Sotiriou, Christos, Shostak, Kateryna, Koch, Alexander, Duterque-Coquillaud, Martine, Krayem, Mohammad, Teixeira, Luis, Limbach, Patrick A., Wimana, Zéna, Morandini, Renato, Rizzotto, Lara, Garaud, Soizic, Ross, Robert L., Desmedt, Christine, Singh, Nitesh Kumar, Menschaert, Gerben, Ghanem, Ghanem, Close, Pierre, Jeschke, Jana, Willard-Gallo, Karen, Leucci, Eleonora, Rothé, Françoise, Hassabi, Bouchra, Lehmann-Che, Jacqueline, Jia, Yan, Dube, Gaurav, Bareche, Yacine, Leroy, Xavier, Chariot, Alain, Marine, Jean-Christophe, Bizet, Martin, Al Wardi, Clémence, Calonne, Emilie, Guo, Mingzhou, Fuks, François

2021

Overview

Post-transcriptional modifications of RNA constitute an emerging regulatory layer of gene expression. The demethylase fat mass- and obesity-associated protein (FTO), an eraser of N6-methyladenosine (m6A), has been shown to play a role in cancer, but its contribution to tumor progression and the underlying mechanisms remain unclear. Here, we report widespread FTO downregulation in epithelial cancers associated with increased invasion, metastasis and worse clinical outcome. Both in vitro and in vivo, FTO silencing promotes cancer growth, cell motility and invasion. In human-derived tumor xenografts (PDXs), FTO pharmacological inhibition favors tumorigenesis. Mechanistically, we demonstrate that FTO depletion elicits an epithelial-to-mesenchymal transition (EMT) program through increased m6A and altered 3′-end processing of key mRNAs along the Wnt signaling cascade. Accordingly, FTO knockdown acts via EMT to sensitize mouse xenografts to Wnt inhibition. We thus identify FTO as a key regulator, across epithelial cancers, of Wnt-triggered EMT and tumor progression and reveal a therapeutically exploitable vulnerability of FTO-low tumors.Fuks and colleagues report that downregulation of the FTO m6A RNA demethylase activates the Wnt pathway, promoting EMT-mediated progression of epithelial tumors and conferring sensitivity to Wnt inhibitors.

• Publisher: Nature Publishing Group,Nature Research
• Subject: Biochemistry, biophysics & molecular biology / Biochimie, biophysique & biologie moléculaire / Breast cancer / Cancer Research / Experiments / Glioma / Life sciences / Mass spectrometry / Metabolism / Metastasis / Oncology / Physiology / Sciences du vivant / Scientific imaging / Tumorigenesis / Tumors / Variance analysis